Over many years, CRT has built up a global network of commercial contacts and tools which help it effectively transfer inventions to commercial partners. CRT business managers can assess which companies have the greatest likelihood of achieving patient benefit from scientists' inventions.

This is achieved through an assessment of the immediate development needs of projects, an up-to-date awareness of what is happening in the industry and knowledge of the particular focus of companies developing oncology-based products.